Its high abundance in cancer is probably associated with changes in mucins expression associated with CRC progression, including an upregulation of MUC5AC and downregulation of MUC2 [164], and even the loss of its expression in some patients [165]. The gene discussed is MUC5AC; the disease is colorectal carcinoma.